85 related articles for article (PubMed ID: 2959964)
1. Thromboxane A2 does not play a role in the development or maintenance of hypertension in spontaneously hypertensive rats.
Stegmeier K; Sponer G; Pill J
Prog Clin Biol Res; 1987; 242():253-7. PubMed ID: 2959964
[No Abstract] [Full Text] [Related]
2. Blood pressure effects of thromboxane A2 blockade in spontaneously hypertensive rats.
Boussairi EH; Sacquet J; Benzoni D; Sassard J
Clin Exp Pharmacol Physiol; 1993 Nov; 20(11):679-87. PubMed ID: 8306513
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of thromboxane A2 receptor blockade in genetically hypertensive rats of the Lyon strain.
Geoffroy J; Benzoni D; Sassard J
J Hypertens Suppl; 1989 Dec; 7(6):S272-3. PubMed ID: 2534414
[TBL] [Abstract][Full Text] [Related]
4. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats.
Mistry M; Nasjletti A
J Pharmacol Exp Ther; 1990 Apr; 253(1):90-4. PubMed ID: 2139470
[TBL] [Abstract][Full Text] [Related]
5. Thromboxane A2/prostaglandin H2 receptor antagonists.
Le Breton GC; Lim CT; Vaidya CM; Venton DL
Methods Enzymol; 1990; 187():406-14. PubMed ID: 2146463
[No Abstract] [Full Text] [Related]
6. Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat.
Quest DW; Wilson TW
Jpn J Pharmacol; 1998 Dec; 78(4):479-86. PubMed ID: 9920205
[TBL] [Abstract][Full Text] [Related]
7. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
Schumacher WA; Heran CL
J Pharmacol Exp Ther; 1989 Mar; 248(3):1109-15. PubMed ID: 2522985
[TBL] [Abstract][Full Text] [Related]
8. Thromboxane synthase inhibition enhances action of converting enzyme inhibitors.
Levens NR; Ksander GM; Zimmerman MB; Mullane KM
Hypertension; 1989 Jan; 13(1):51-62. PubMed ID: 2910814
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane A2 and the development of hypertension in spontaneously hypertensive rats.
Stier CT; Itskovitz HD
Eur J Pharmacol; 1988 Jan; 146(1):129-35. PubMed ID: 3350054
[TBL] [Abstract][Full Text] [Related]
10. Influence of thromboxane metabolism interference on glycemia regulation in rats.
Nechifor M; Busuioc A; Cocu F
Rev Med Chir Soc Med Nat Iasi; 1988; 92(3):555-7. PubMed ID: 2977856
[No Abstract] [Full Text] [Related]
11. Endothelin-1 blockade prevents COX2 induction and TXA2 production in the fructose hypertensive rat.
Jiang J; Tran L; Vasudevan H; Xia Z; Yuen VG; McNeill JH
Can J Physiol Pharmacol; 2007; 85(3-4):422-9. PubMed ID: 17612651
[TBL] [Abstract][Full Text] [Related]
12. Thromboxane synthetase inhibitor UK38,485 lowers blood pressure in the adult spontaneously hypertensive rat.
Uderman HD; Jackson EK; Puett D; Workman RJ
J Cardiovasc Pharmacol; 1984; 6(5):969-72. PubMed ID: 6209508
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a prostacyclin analog, iloprost, and a thromboxane A2 receptor antagonist, daltroban, in experimental intimal hyperplasia.
Levitt MA; Dryjski M; Tluczek J; Bjornsson TD
Prostaglandins; 1991 Jan; 41(1):1-6. PubMed ID: 1708508
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.
Humphrey PP; Hallet P; Hornby EJ; Wallis CJ; Collington EW; Lumley P
Circulation; 1990 Jan; 81(1 Suppl):I42-52; discussion I59-60. PubMed ID: 2136817
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiological responses of the cochlea to transient asphyxia are influenced by arachidonate metabolites.
Ernst A; Syka J; Mest HJ
Prostaglandins; 1992 Apr; 43(4):331-8. PubMed ID: 1535163
[TBL] [Abstract][Full Text] [Related]
16. Thromboxane synthesis and blood pressure in spontaneously hypertensive rats.
Purkerson ML; Martin KJ; Yates J; Kissane JM; Klahr S
Hypertension; 1986 Dec; 8(12):1113-20. PubMed ID: 3793195
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of a new specific thromboxane antagonist in arachidonate-induced sudden death.
Lefer DJ; Mentley RK; Lefer AM
Arch Int Pharmacodyn Ther; 1987 May; 287(1):89-95. PubMed ID: 2957969
[TBL] [Abstract][Full Text] [Related]
18. Role of the prostaglandin-thromboxane system in the development and maintenance of spontaneous hypertension in the rat.
Yasujima M; Abe K; Tanno M; Kohzuki M; Sato M; Omata K; Takeuchi K; Hagino T; Yoshinaga K
Agents Actions Suppl; 1987; 22():133-8. PubMed ID: 3124554
[TBL] [Abstract][Full Text] [Related]
19. Decrease in arterial blood pressure in spontaneously hypertensive rats by the TXA2 receptor antagonist BM 13177 and by acetylsalicylic acid.
Köhler AH; Köhler AR; Taube C; Mest HJ
Biomed Biochim Acta; 1988; 47(10-11):S269-73. PubMed ID: 2977724
[TBL] [Abstract][Full Text] [Related]
20. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms.
Xavier FE; Davel AP; Fukuda LE; Rossoni LV
J Hypertens; 2009 Jun; 27(6):1233-42. PubMed ID: 19337130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
